Moreover, the proportion of patients at high risk according to BNP/NT-proBNP cut off levels was significantly higher (p < 0.05, chi-square for trend) in PAH patients with bioavailable 25(OH)vitD levels below the median (Figure 5D). Here, NPPB is linked to pulmonary arterial hypertension.